glp-1 kidney outcomes news today Renal of SGLT2 inhibitors and GLP1 agonists in clinical practice GLP-1 and the kidney: from

Research suggests that about 1 in 12 people using semaglutide medications may experience this

Should I stop taking GLP-1 medication if my period becomes irregular

Prepare for potential shortages Be proactive in refilling prescriptions before you run out, especially for medications where shortages are anticipated

Patients are generally considered eligible if they meet the following criteria: BMI of 40 kg/m or above , or BMI of 3539.9 kg/m with a significant obesity-related comorbidity such as type 2 diabetes, hypertension, obstructive sleep apnoea, or non-alcoholic fatty liver disease All appropriate non-surgical measures have been tried but have failed to achieve or maintain adequate clinically beneficial weight loss The patient is fit for anaesthesia and surgery The patient commits to long-term follow-up NICE CG189 also recommends that bariatric surgery should be considered as a first-line option for adults with a BMI over 50 kg/m, where surgical intervention may be more clinically appropriate than prolonged conservative management

Just focus on portion control and eating at a comfortable pace

Ro works with both brand and compounded GLP-1s